ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION RECIPIENT
Clinical trials for ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION RECIPIENT explained in plain language.
Never miss a new study
Get alerted when new ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION RECIPIENT trials appear
Sign up with your email to follow new studies for ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION RECIPIENT, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New strategy aims to stop transplant complications in kids with blood cancer
Disease control Recruiting nowThis study tests a new way to prevent chronic graft-versus-host disease (GVHD) in children and young adults with blood cancers who receive a donor stem cell transplant. Researchers remove a specific type of immune cell (naive T cells) from the donor cells before transplant to red…
Matched conditions: ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION RECIPIENT
Phase: PHASE2 • Sponsor: Fred Hutchinson Cancer Center • Aim: Disease control
Last updated May 17, 2026 01:29 UTC
-
Pre-Transplant fitness program aims to boost recovery in blood cancer patients
Disease control Recruiting nowThis study tests whether a personalized exercise and nutrition program before a stem cell transplant can improve quality of life and recovery for adults with blood cancer. About 110 participants will be randomly assigned to the program or standard care. The goal is to reduce hosp…
Matched conditions: ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION RECIPIENT
Phase: NA • Sponsor: Rigshospitalet, Denmark • Aim: Disease control
Last updated May 17, 2026 01:17 UTC
-
Immune cell boost shows promise against Post-Transplant viruses
Disease control Recruiting nowThis study tests whether specially trained white blood cells from a donor can safely fight off cytomegalovirus (CMV) or adenovirus infections in people who have had a stem cell or solid organ transplant. About 20 participants will receive these virus-fighting cells to see if they…
Matched conditions: ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION RECIPIENT
Phase: EARLY_PHASE1 • Sponsor: Sumithira Vasu • Aim: Disease control
Last updated May 11, 2026 20:53 UTC